Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
about
Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patientsPhenotypic mutants of the intracellular actinomycete Rhodococcus equi created by in vivo Himar1 transposon mutagenesisCharacterization of an aromatic amino acid-dependent Listeria monocytogenes mutant: attenuation, persistence, and ability to induce protective immunity in mice.Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector.The delicate balance in genetically engineering live vaccines.Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.Questions about the behaviour of bacterial pathogens in vivo.Development of a nonantibiotic dominant marker for positively selecting expression plasmids in multivalent Salmonella vaccines.Salmonella enterica serovar typhimurium surA mutants are attenuated and effective live oral vaccinesPhase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers.Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.Engineered external guide sequences are highly effective in inhibiting gene expression and replication of hepatitis B virus in cultured cells.Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensisEngineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strainAttenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosisSafety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral InfectionOral immunization using live attenuated Salmonella spp. as carriers of foreign antigens.Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccinesEffective inhibition of cytomegalovirus infection by external guide sequences in mice.Construction of delta aroA his delta pur strains of Salmonella typhiOral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoitesVaccination against typhoid fever: present statusInhibition of hepatitis B virus gene expression and replication by ribonuclease P.Indirect measurement of intestinal immune responses to an orally administered attenuated bacterial vaccine.Natural killer cells mediate protection induced by a Salmonella aroA mutant.Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice.Immunogenicity of Salmonella typhi Ty21a vaccine for young childrenVolunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.
P2860
Q24564924-AE858CAA-CCB2-4BEE-A804-C20A3BAB60F8Q30724941-9691913D-934E-4405-A352-60605EB79287Q33598287-7223056D-4C5E-4BC7-8FC3-AE881AD0FE6AQ33613680-A9299F04-F246-4EBE-AF47-490121063E87Q33801051-B88CBD2A-8C60-4807-AE3B-E8B6C22E30C7Q33829995-49996872-DC33-4A07-A5E8-FDE01633292DQ33842038-3E244CB7-62BA-472B-AED4-396AB3BF8225Q33955457-640FBD88-7259-42F4-9CAA-0FFEB5E1C10DQ33986816-AC9E663C-B543-4E08-9FF1-36B8AC477A81Q34003465-BA10C64B-0F65-4639-B5D9-E3D67B266627Q34003500-20F9339D-13F8-407F-B17B-617218546F47Q34008449-B5CE0834-2391-4AC7-98B0-3F7F39077D65Q34528102-0FB6E012-DA27-4E8F-8692-5EFE273B9476Q34602827-EAC921DA-25D3-4825-906A-555B02371DB4Q34775644-A111FD3C-EE50-4618-9011-354272C0638EQ35097492-40AB89E0-A9A0-4E24-9196-197B425EF0AAQ35399988-1B8D49F8-E6D3-4E10-8888-28BD23A9AFE5Q35406291-65BDE40F-3D6E-4E55-93EB-8A49E5B309F2Q35485187-9B0D9BB4-6A6D-49A6-839B-9971A71AFF24Q35502485-533D99F6-08DE-4BC3-B78F-37E71EB7B0E2Q35510455-274B227A-9333-4848-AE87-B948C5350773Q35532132-42A60E1A-65F9-4531-B9B3-2AA4FC733E8BQ35552012-C7574E26-797F-44F1-97C0-304CEE025318Q35553394-CD5EEB12-CBA6-4A0D-A442-9CF065090143Q35604978-7132CAE1-ED19-4E09-9FF0-367A395CF216Q35666065-8B31A1D6-4271-4560-94CD-DB165600D3FEQ35677333-B769B651-EBDA-4CE2-AB26-1D6CAD2CCD26Q35783750-8DD49312-9663-4608-A049-0FDDFD431C5CQ36167599-23CE8C95-2304-4C25-A6FF-708261347AA7Q36213903-BAC10B79-034F-4FDE-A3AB-4BE0D63E000FQ36353575-1FE9E50B-6B52-4252-9E3A-8956400A7FBDQ36653379-89C299BB-A1F0-4900-B966-A325B086B91CQ36668519-187982D5-B7F8-4205-858D-55C3F98C2EFCQ36794750-A21DA75B-677A-460A-A0D1-0DCE6ACE6279Q36883874-EDB7CBFB-5D93-4266-B57D-D9A901022321Q36945363-55D5C8F4-79C4-4FA8-B338-ACEE12B34068Q36955180-13E62739-F282-4735-AEEB-02D1A42F7A08Q36974782-7405C20B-FEEB-40A1-AB96-3986ECC5C82AQ36989511-EDE925DA-C453-4F74-8D3A-FE11D07C8973Q36992602-D7DF005A-A27D-4770-95FE-748A635955C3
P2860
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
description
1987 nî lūn-bûn
@nan
1987 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի մարտին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@ast
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@en
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@nl
type
label
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@ast
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@en
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@nl
prefLabel
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@ast
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@en
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@nl
P2093
P2860
P356
P1476
Safety, infectivity, immunogen ...... live oral vaccines in humans.
@en
P2093
A A Lindberg
D Herrington
G Losonsky
J G Morris
J R Murphy
M F Edwards
M M Levine
P2860
P304
P356
10.1172/JCI112899
P407
P577
1987-03-01T00:00:00Z